Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (131-140 of 289) with videos related to

Pageof 29
Sort By:
Psycho-Oncology|October 15, 2013
Stigma among patients with lung cancer: a patient-reported measurement modelHeidi A Hamann, Jamie S Ostroff, Emily G Marks, et al.
Journal of Oncology Practice|October 19, 2012
Consent timing and experience: modifiable factors that may influence interest in clinical researchDavid E Gerber, Drew W Rasco, Celette Sugg Skinner, et al.
Cancer Medicine|April 23, 2020
Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resectionMitchell S von Itzstein, Rong Lu, Kemp H Kernstine, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2014
Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancerRaghunadharao Digumarti, P P Bapsy, Attili V Suresh, et al.
Patient Education and Counseling|June 27, 2019
Patient and provider perspectives on delivery of oral cancer therapiesCaitlin C Murphy, Simon J Craddock Lee, David E Gerber, et al.
JCO Clinical Cancer Informatics|February 26, 2019
Mobile Device Applications for Electronic Patient Portals in OncologyKelvin K Pho, Rong Lu, Samantha Gates, et al.
The Oncologist|January 11, 2024
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung CancerDavid E Gerber, Yating Wang, Suresh S Ramalingam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2011
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumorsDavid E Gerber, Alison T Stopeck, Lucas Wong, et al.
Journal of Oncology Practice|July 10, 2014
Predictors and intensity of online access to electronic medical records among patients with cancerDavid E Gerber, Andrew L Laccetti, Beibei Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2017
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and ComplexitySandra Garcia, Ajit Bisen, Jingsheng Yan, et al.
Pageof 29

Showing results (131-140 of 289) with videos related to

Sort By:
Pageof 29
Psycho-Oncology|October 15, 2013
Stigma among patients with lung cancer: a patient-reported measurement modelHeidi A Hamann, Jamie S Ostroff, Emily G Marks, et al.
Journal of Oncology Practice|October 19, 2012
Consent timing and experience: modifiable factors that may influence interest in clinical researchDavid E Gerber, Drew W Rasco, Celette Sugg Skinner, et al.
Cancer Medicine|April 23, 2020
Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resectionMitchell S von Itzstein, Rong Lu, Kemp H Kernstine, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2014
Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancerRaghunadharao Digumarti, P P Bapsy, Attili V Suresh, et al.
Patient Education and Counseling|June 27, 2019
Patient and provider perspectives on delivery of oral cancer therapiesCaitlin C Murphy, Simon J Craddock Lee, David E Gerber, et al.
JCO Clinical Cancer Informatics|February 26, 2019
Mobile Device Applications for Electronic Patient Portals in OncologyKelvin K Pho, Rong Lu, Samantha Gates, et al.
The Oncologist|January 11, 2024
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung CancerDavid E Gerber, Yating Wang, Suresh S Ramalingam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2011
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumorsDavid E Gerber, Alison T Stopeck, Lucas Wong, et al.
Journal of Oncology Practice|July 10, 2014
Predictors and intensity of online access to electronic medical records among patients with cancerDavid E Gerber, Andrew L Laccetti, Beibei Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2017
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and ComplexitySandra Garcia, Ajit Bisen, Jingsheng Yan, et al.
Pageof 29